Product Images Edaravone
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Edaravone NDC 0781-3527 by Sandoz Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
chem-structure - edaravone 01
figure-1 - edaravone 02
This text provides information related to a comparison study between Edaravone injection and Placebo for ALS (Amyotrophic Lateral Sclerosis) patients. The study evaluates the change in ALSFRS-R (Amyotrophic Lateral Sclerosis Functional Rating Scale - Revised) at Week 24, suggesting that the effectiveness of Edaravone injection is being compared to the placebo in improving the condition of ALS patients.*
carton - edaravone 03
This is a description of Edaravone Injection, a medication with the NDC 0781-3527-20, manufactured by Sandoz. Each 100 mL bag contains 30 mg of edaravone, with other inactive ingredients added for stability and pH adjustment. It is a sterile solution for intravenous infusion, to be administered over a 30-minute period. The package insert provides detailed information on dosage and administration. It is a single-dose medication, and any unused portion must be discarded. The storage instructions include keeping it at 20° to 25°C (68° to 77°F) and protecting it from light. The caution advises against swallowing, and if leaks are found, the bag should be discarded to maintain sterility.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
